Skip to main content
Premium Trial:

Request an Annual Quote

Caris Life Sciences: George Sledge

Caris Life Sciences has appointed George Sledge as its executive VP and chief medical officer. He will oversee the firm's medical affairs, research, and medical education, including the Caris Precision Oncology Alliance and the company's team of medical science liaisons. Prior to joining Caris, Sledge was professor of medicine in the oncology division at Stanford University School of Medicine. He was most recently co-director of the Stanford Cancer Institute's cancer therapeutics program and served as chief of the division of oncology from 2013 to 2020. He has also held various other positions, including chair of the Eastern Cooperative Oncology Group's Breast Cancer Committee, member of the US Food and Drug Administration's Oncology Drug Advisory Committee, member of the Integration Panel within the Department of Defense's Breast Cancer Research Program, and member of the National Cancer Institute's Clinical Trials Advisory Board. He is the past president of the American Society of Clinical Oncology.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.